# Damon Bass

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/damon-bass/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,342 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 19 |
| i10-index | 25 |
| OpenAlex ID | https://openalex.org/A5047601269 |
| ORCID iD | 0000-0003-2480-5674 |
| Works | 38 |

## Researcher papers

- [Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty‐Two–Week Randomized, Double‐Blind, Placebo‐Controlled Study](https://scholariq.org/papers/efficacy-and-safety-of-subcutaneous-belimumab-in-systemic-lupus-erythematosus-a/)
- [A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea](https://scholariq.org/papers/a-pivotal-phase-iii-randomised-placebo-controlled-study-of-belimumab-in-patients/)
- [Incidence and US Costs of Corticosteroid-Associated Adverse Events: A Systematic Literature Review](https://scholariq.org/papers/incidence-and-us-costs-of-corticosteroid-associated-adverse-events-a-systematic/)
- [Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression](https://scholariq.org/papers/systemic-lupus-erythematosus-lupus-nephritis-and-end-stage-renal-disease-a/)
- [A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis](https://scholariq.org/papers/a-secondary-analysis-of-the-belimumab-international-study-in-lupus-nephritis/)
- [Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial](https://scholariq.org/papers/safety-and-efficacy-of-intravenous-belimumab-in-children-with-systemic-lupus/)
- [Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan](https://scholariq.org/papers/healthcare-utilization-and-cost-of-systemic-lupus-erythematosus-in-a-us-managed/)
- [Phase <scp>III</scp>/<scp>IV</scp>, Randomized, <scp>Fifty‐Two</scp>–Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus](https://scholariq.org/papers/phase-scp-iii-scp-scp-iv-scp-randomized-scp-fifty-two-scp-week-study-of-the/)
- [Efficacy and Safety of Subcutaneous Belimumab in Anti–Double‐Stranded <scp>DNA</scp>–Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus](https://scholariq.org/papers/efficacy-and-safety-of-subcutaneous-belimumab-in-anti-double-stranded-scp-dna/)
- [A randomized, open-label study to investigate the effect of belimumab on pneumococcal vaccination in patients with active, autoantibody-positive systemic lupus erythematosus](https://scholariq.org/papers/a-randomized-open-label-study-to-investigate-the-effect-of-belimumab-on/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)
- [Vagus Nerve Stimulation Research](https://scholariq.org/topics/vagus-nerve-stimulation-research/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.